Company intelligence / Profile preview

Future Pharmaceutical Industries

Egypt

Ownership: Private
Development stage: Other

Overview

FPI commercially manufactures pharmaceutical products across nearly all therapeutic classes, supplying high-quality branded and generic drugs, advanced dietary supplements, and providing contract development and manufacturing for national and multinational clients. Recognized for cGMP, ISO 9001, FDA, and EMA compliance. No pivotal clinical trial-derived drug launches disclosed.

Therapeutic areas: EndocrinologyRheumatologyInfectious DiseasesGastroenterologyPulmonologyDermatologyCardiovascularOtherNeurology
Modalities: Small moleculePeptidesProteinAntibodyBiologicGene synthesis
Industry: Contract Manufacturing Organization

Partnerships

Contracts with multinational and national companies for manufacturing (not specifically named)

Beyond the preview

Go deeper on Future Pharmaceutical Industries.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Future Pharmaceutical Industries.

Explore the full profile